received a bachelors degree in Chemistry from Carnegie Mellon University and a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology. After doctoral studies, Dr. Elisseeff was a Fellow at the National Institute of General Medical Sciences Pharmacology Research Associate Program. In 2001, Dr. Elisseeff became an assistant professor in the Department of Biomedical Engineering at Johns Hopkins University. In 2004, Elisseeff cofounded Cartilix, Inc., that was sold to Biomet in 2009. Dr. Elisseeff now holds the Jules Stein Chair in the Wilmer Institute and is Director of the Translational Tissue Engineering Center (TTEC). She serves on the Scientific Advisory Board of Bausch and Lomb, Kythera Biopharmaceutical, and Cellular Bioengineering Inc. Dr. Elisseeff has received awards including the Carnegie Mellon Young Alumni Award, Arthritis Investigator Award from the Arthritis Foundation, Yasuda Award from the Society of Physical Regulation in Medicine and Biology, and was named by Technology Review magazine as a top innovator under 35 in 2002 and top 10 technologies to change the future. In 2008, Dr. Elisseeff was elected a fellow in the American Institute for Medical and Biological Engineering and a Young Global Leader in the World Economic Forum. She has published over 110 articles, book chapters and patent applications and given over 130 national and international invited lectures.
has a long experience in managing innovation and global affairs in large industrial groups such as Roche and IRI, the largest Italian Industrial Holding from 1985 to 2000. He has been CEO of Tecnitel a TLC manufacturing company and was Special Advisor for Science and Technology policies to the president of the European Commission and to the Italian Prime Minister. He is now serving as an independent Board Member in several listed companies (STM, TiMedia, American Funds, etc) and academia institutions such as CMU and IIT. He is the publisher of the Italian Edition of Technology Review, the MIT magazine of innovation. He is married to Dr. Elisseeff.
is a corporate securities lawyer with Greenberg Traurig, a multi-national law firm. He has represented both private and public technology companies. He has worked with a number of startup companies that have gone on to become public companies. Mr. Marks was Senior Deputy Legal Advisor in the State Department in the late 1970s.